◀ Back to ATP5O

ATP5O — IL6

Text-mined interactions from Literome

Gloss et al., Am J Physiol Endocrinol Metab 2000 : We investigated the effects of the leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) on 3,3 ', 5-triiodo-L-thyronine, or thyroid hormone ( T ( 3 ) ) -stimulated sarcoplasmic reticulum Ca ( 2+ ) ATPase ( SERCA2 ) gene expression on cultured neonatal rat cardiac myocytes
Tanaka et al., J Int Med Res 2004 : We investigated the effect of interleukin-6 (IL-6) expression on sarco/endoplasmic reticulum Ca ( 2+ ) -ATPase ( SERCA ), atrial natriuretic peptide (ANP) and B-type natriuretic peptide ( BNP ) mRNA levels in cultured rat neonatal ventricular myocytes
Chan et al., J Food Sci 2009 (Neurodegenerative Diseases) : H ( 2 ) O ( 2 ) or MPP ( + ) treatment significantly decreased Na ( + ) -K ( + ) -ATPase activity, elevated caspase-3 activity and levels of interleukin (IL)-1, IL-6 , and tumor necrosis factor (TNF)-alpha ( P < 0.05 ) ; and the pretreatments from these agents significantly restored Na ( + ) -K ( + ) -ATPase activity, suppressed caspase-3 activity and release of IL-1, IL-6, and TNF-alpha ( P < 0.05 )